$ILMN Recent News Apple shares rise past $100 after

New Post Public Reply Private Reply Replies (0) Message Board

Oct 31, 2014 at 12:58 PM

$ILMN Recent News

Apple shares rise past $100 after Street beat 6:20 p.m. Oct. 20, 2014 - Wallace Witkowski
During times like these, cash is king 2:04 p.m. Oct. 2, 2014 - The Trading Deck
Two tech stocks with big potential 2:15 p.m. Sept. 11, 2014 - The Trading Deck
More reasons to like the Nasdaq in September 3:14 p.m. Sept. 4, 2014 - The Trading Deck
Good times for stocks lie ahead 1:47 p.m. Aug. 28, 2014 - The Trading Deck
Roche to buy InterMune for $8.3 billion 10:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Raiffeisen rallies, miners slip: Europe movers 12:04 p.m. Aug. 21, 2014 - Sara Sjolin
Miners drop in London after weak China PMI 12:02 p.m. Aug. 21, 2014 - Sara Sjolin
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Growth stocks are doing most bullish thing they can 3:24 p.m. July 1, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
What Apple needs next is this 1:28 p.m. May 8, 2014 - Cody Willard
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
Let Ilumina brighten up your portfolio 4:02 p.m. Jan. 30, 2014 - The Trading Deck
Illumina gets mileage out of earnings as industry declines 11:51 a.m. Jan. 29, 2014 - Russ Britt
Illumina shares up on plan to tap $20 billion gene-sequencing market 1:06 p.m. Jan. 17, 2014 - Russ Britt
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 5:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh

Illumina (ILMN) Hits New Lifetime High 9:47 a.m. Today - TheStreet.com
Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape 9:46 a.m. Today - Zacks.com
Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog 2:50 p.m. Oct. 30, 2014 - Zacks.com
Cara Therapeutics (CARA) Worth Watching: Stock Rises 6.4% - Tale of the Tape 9:39 a.m. Oct. 30, 2014 - Zacks.com
Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape 9:25 a.m. Oct. 30, 2014 - Zacks.com
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape 8:51 a.m. Oct. 30, 2014 - Zacks.com
10-Q: ILLUMINA INC 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Illumina's Break Could Be Investor's Gain 2:00 p.m. Oct. 29, 2014 - benzinga.com
The Medicines Company (MDCO) Jumps: Stock Gains 16.5% - Tale of the Tape 9:25 a.m. Oct. 29, 2014 - Zacks.com
Chipotle And Apple Suppliers Rise Among 5 Young Guns 7:02 a.m. Oct. 29, 2014 - Investors Business Daily
Gilead (GILD) Posts Weak Earnings; Stock Falls 4% After-Hours - Stocks in the News 11:58 p.m. Oct. 28, 2014 - Zacks.com
Novavax (NVAX) in Focus: Stock Rises 13% - Tale of the Tape 8:44 a.m. Oct. 28, 2014 - Zacks.com
Can Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape 8:41 a.m. Oct. 28, 2014 - Zacks.com
Four Biotechs Lead Health Care Stocks In Big Cap 20 6:00 p.m. Oct. 27, 2014 - Investors Business Daily
ILMN: Buy Into Illumina’s Perfect Quarter 9:55 a.m. Oct. 27, 2014 - InvestorPlace.com
Verastem (VSTM) Shows Strength: Stock Adds 7% in Session - Tale of the Tape 9:39 a.m. Oct. 27, 2014 - Zacks.com
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 8% - Tale of the Tape 8:51 a.m. Oct. 27, 2014 - Zacks.com

HTG Announces Completion of IVD Development and Supply Agreement With Illumina 7:03 a.m. Oct. 30, 2014 - Marketwired
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 8:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, NQ Mobile, SunEdison, Illumina and Qihoo 360 Technology Released By InvestorsObserver 9:31 a.m. Oct. 21, 2014 - PR Newswire - PRF
Illumina Reports Record Financial Results for Third Quarter of Fiscal Year 2014 4:06 p.m. Oct. 20, 2014 - BusinessWire - BZX
Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems 6:30 a.m. Oct. 17, 2014 - BusinessWire - BZX
Illumina Accelerator Announces Investment in Inaugural Startup Class 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Affordable Housing Project, Lawsuit Settlement, Drug Review, and Earnings Release Schedules - Research Reports on UnitedHealth, Bristol-Myers, Boston Scientific, Abbott and Illumina 8:55 a.m. Oct. 14, 2014 - PR Newswire - PRF
Illumina to Announce Third Quarter 2014 Financial Results on Monday, October 20, 2014 6:30 a.m. Oct. 6, 2014 - BusinessWire - BZX
AB SCIEX and Illumina Collaborate to Create World’s First Multi-omics Cloud-Computing Environment 6:30 a.m. Oct. 2, 2014 - BusinessWire - BZX
Critical Alerts For Discovery Communications, GlaxoSmithKline, Illumina, Teekay and Gulfport Energy Released By InvestorsObserver 9:31 a.m. Oct. 1, 2014 - PR Newswire - PRF
Project Update, Awards, Appointment, Product Launch, and Sponsorship - Research Reports on D.R. Horton, Mallinckrodt, Illumina, Ventas and Capital One Financial 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Human Identification Market Growing at 13.9% CAGR to 2018 2:20 p.m. Sept. 26, 2014 - PR Newswire - PRF
Life Sciences Tools and Services Equities Technical Data - PerkinElmer, Agilent Technologies, Bruker, Sequenom, and Illumina 8:50 a.m. Sept. 22, 2014 - PR Newswire - PRF
Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Sept. 9, 2014 - GlobeNewswire
Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions 6:30 a.m. Sept. 8, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 9:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Aug. 27, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018 6:02 p.m. Aug. 25, 2014 - PR Newswire - PRF
The Global Non-Invasive Prenatal Diagnostics Market 1:12 p.m. Aug. 19, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ad Council Expands Board, Taps Meta Exec as Vice Chair

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Georgia-Pacific's $150M Bet on Bathroom Tissue Future

Georgia-Pacific is throwing down a cool $150 million to jazz up its mill in Palatka, Florida. Yep, they're not just scrubbing the edges, but rebuilding one of the paper machines there—from the ground up. Why the fuss? Well, in the paper game, keeping your machines ahead of the pack means everything. In this case, it’s about ramping up for dear ol’ Angel Soft® bath...

Nektar Therapeutics Gears Up for Q3 Financial Reveal

Anticipation Builds as Nektar Preps Financial Report Ah, the life of a biotech investor, riding high or gripping the rail as tides turn with every quarterly report. This time, we're turning our gaze to Nektar Therapeutics and their Q3 financial results slated for release on November 12th, just as the market dust starts settling for the day. Now, if you’re wired to...

Custom Homes Shine: Florida’s Lucrative Property Move

Why Custom Homes Are Worth the Investment in Florida Ever thought about sinking some cash into Florida's real estate game? Well, building a custom home might just be your golden ticket, according to Paul H Schaefer II from Sage Homes LLC. I mean, everyone knows Florida's housing market is as spicy as a chili pepper, but custom homes seem to be the secret sauce here....

Firmable Climbs G2 Ranks in Sales Intelligence

Success stories aren't written overnight, and Firmable's recent leap in G2's rankings proves that point. This AI-native B2B sales powerhouse has muscled its way from #8 to #4 on the global Momentum Grid for Sales Intelligence, marking a dramatic rise that's hard to ignore. Being recognized at this level shows the company's on a solid path, but let's see what makes this...

Webull Faces Class Action: Deadline Looms Dec 2026

Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...

Oracle's Bold Vision: Targeting $225B Revenue by 2030

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Software Updates Costly: UX Not the Biggest Culprit

Breaking Updates Trump UX Changes Here's the real scoop: software updates that break functionality are setting companies back more than those user experience (UX) tweaks that folks gripe about but usually muddle through. According to a recent LITSLINK study, even three figures that supposedly quantify UX losses turn out to be questionable at best. Real-world Disasters:...

LabWare Loop: A Game Changer for Lab Data Integrity

Breaking Down Silos in Lab Environments When it comes to the controlled chaos of laboratory operations, data integrity is the name of the game. We're talking about a new way of doing things that doesn't demand a physics degree just to connect the dots between gizmos and databases. Enter LabWare Loop, a solution that's rewriting the data playbook by linking multi-vendor...

SELCO and Numerica Unite: A Merger That's All Heart

Big Merger in Credit Union World: SELCO and Numerica Sometimes, it ain't all about dollars and cents. That's the vibe I'm picking up from this merger of equals between SELCO Community and Numerica Credit Unions. This isn't a Wall Street hustle, it's hometown hustle—where the biggest reward isn't just a fat line at the bottom but seeing your community thrive. The Vision...